IKK␣ regulates many chromatin events in the nuclear phase of the NF-B program, including phosphorylation of histone H3 and removal of co-repressors from NF-B-dependent promoters. However, all of the nuclear functions of IKK␣ are not understood. In this study, using mouse embryonic fibroblasts IKK␣ knock-out and reexpressing IKK␣ after retroviral transduction, we demonstrate that IKK␣ contributes to NF-B/p65 DNA binding activity on an exogenous B element and on some, but not all, endogenous NF-B-target promoters. Indeed, p65 chromatin immunoprecipitation assays revealed that IKK␣ is crucial for p65 binding on B sites of icam-1 and mcp-1 promoters but not on ib␣ promoter. The mutation of IKK␣ putative nuclear localization sequence, which prevents its nuclear translocation, or of crucial serines in the IKK␣ activation loop completely inhibits p65 binding on icam-1 and mcp-1 promoters and rather enhances p65 binding on the ib␣ promoter. Further molecular studies demonstrated that the removal of chromatin-bound HDAC3, a histone deacetylase inhibiting p65 DNA binding, is differentially regulated by IKK␣ in a promoter-specific manner. Indeed, whereas the absence of IKK␣ induces HDAC3 recruitment and repression on the icam-1 promoter, it has an opposite effect on the ib␣ promoter, where a better p65 binding occurs. We conclude that nuclear IKK␣ is required for p65 DNA binding in a gene-specific manner.
IKK␣ regulates many chromatin events in the nuclear phase of the NF-B program, including phosphorylation of histone H3 and removal of co-repressors from NF-B-dependent promoters. However, all of the nuclear functions of IKK␣ are not understood. In this study, using mouse embryonic fibroblasts IKK␣ knock-out and reexpressing IKK␣ after retroviral transduction, we demonstrate that IKK␣ contributes to NF-B/p65 DNA binding activity on an exogenous B element and on some, but not all, endogenous NF-B-target promoters. Indeed, p65 chromatin immunoprecipitation assays revealed that IKK␣ is crucial for p65 binding on B sites of icam-1 and mcp-1 promoters but not on ib␣ promoter. The mutation of IKK␣ putative nuclear localization sequence, which prevents its nuclear translocation, or of crucial serines in the IKK␣ activation loop completely inhibits p65 binding on icam-1 and mcp-1 promoters and rather enhances p65 binding on the ib␣ promoter. Further molecular studies demonstrated that the removal of chromatin-bound HDAC3, a histone deacetylase inhibiting p65 DNA binding, is differentially regulated by IKK␣ in a promoter-specific manner. Indeed, whereas the absence of IKK␣ induces HDAC3 recruitment and repression on the icam-1 promoter, it has an opposite effect on the ib␣ promoter, where a better p65 binding occurs. We conclude that nuclear IKK␣ is required for p65 DNA binding in a gene-specific manner.
Nuclear factor-B (NF-B) 5 is a key transcription factor involved in the expression of genes regulating innate and adaptive immunity (1), cellular proliferation, survival (2, 3) , and development (4) . NF-B consists of homo-or heterodimers of a group of five proteins, namely NF-B1 (p50 and its precursor p105), NF-B2 (p52 and its precursor p100), p65/RelA, c-Rel, and RelB (5) . In unstimulated cells, NF-B is sequestered in the cytoplasm through its tight association with inhibitory proteins of the IB family, comprising notably IB␣ (5) . Upon cellular stimulation with proinflammatory cytokines, lipopolysaccharide, antigens or viral products, the so-called classical NF-B activation pathway is engaged. IB␣ is rapidly phosphorylated on Ser 32 and Ser 36 , which triggers its polyubiquitination and subsequent degradation by the 26 S proteasome. The freed NF-B then translocates into the nucleus, where it binds B sites and enhances transcription of a large number of genes implicated notably in the inflammatory response (5) . Phosphorylation of IB␣ on Ser 32 and Ser 36 is achieved by the IB kinase (IKK) complex, which includes the scaffold protein NF-B essential modulator (NEMO; also called IKK␥) (6) and the IKK␣ and IKK␤ kinases (7) . A novel NEMO-independent NF-B-activating pathway was recently described. This alternative pathway is engaged notably upon lymphotoxin-␤ or B cell-activating factor induction and enhances NF-B-inducing kinase-and IKK␣-dependent processing of p100 into p52 (8, 9) . This subunit binds DNA in association with its partners and stimulates transcription of genes important for secondary lymphoid organ development, B cell homeostasis, and adaptive immunity (1, 10) . IKK-independent phosphorylation of IB␣ on Tyr 42 has also been reported upon sodium pervanadate or hypoxia/reoxygenation treatment (11) (12) (13) . This tyrosine phosphorylation is mediated by c-Src tyrosine kinase and triggers dissociation/degradation of IB␣ from NF-B complexes, allowing NF-B to translocate into the nucleus (12, 14) . Generation of knock-out mice for IKK complex subunits has revealed that IKK␤ is the main kinase responsible for IB␣ Ser 32 and Ser 36 phosphorylation and that NEMO/IKK␥ assembles the IKKs into a functional kinase complex upon the classical pathway (15) (16) (17) (18) . On the other hand, whereas IKK␣ is crucial for p100 phosphorylation and subsequent NF-B activation through the alternative pathway (10) , in most cases this kinase is not required for the signal-induced phosphorylation of IB␣ in the cytoplasm. Nevertheless, an optimal induction of NF-Bdependent genes through the classical pathway appears to rely on the nuclear translocation of IKK␣ (19) . Indeed, once in the nucleus, IKK␣ acts in a process called derepression that allows full NF-B-mediated transcription by removing repressor complexes, such as SMRT and HDAC3, from target promoters (20) . IKK␣ also phosphorylates histone H3, a component of nucleosomes. This phosphorylation triggers subsequent acetylation of histone H3 on Lys 14 by the IKK␣-associated histone acetyltransferase CREB-binding protein, a crucial step in modulating chromatin accessibility at NF-B-responsive promoters (21) (22) (23) . Besides a role of nuclear IKK␣ in positively regulating NF-B-dependent gene transcription, IKK␣ also limits NF-B activation in LPS-stimulated macrophages by mediating p65 and c-Rel turnover through phosphorylation of their C-terminal part (24) . Some authors have also suggested that IKK␣ contributes to direct p65 DNA binding, since electrophoretic mobility shift assay (EMSA) experiments using ikk␣ Ϫ/Ϫ MEFs or HeLa cells transfected with IKK␣ small interfering RNA exhibit a clear inhibition of NF-B binding activity upon TNF-␣ treatment, despite a quite unaltered IB␣ phosphorylation/degradation (25, 26) . However, these results seemed inconsistent with other reports (27, 28) , including recent data obtained by p65 chromatin immunoprecipitation (ChIP) analysis on several NF-B target genes in ikk␣
MEFs (21, 23) . Such a discrepancy reflects the need to determine whether or not a general mechanism can be drawn for all genes or whether some promoter-specific effects occur.
Here, we have addressed the role of IKK␣ in the control of NF-B/p65 DNA binding in mouse embryonic fibroblasts lacking IKK␣ or complemented with either wild-type (WT) or mutant IKK␣ upon TNF-␣ stimulation. We showed that IKK␣ is required for p65 DNA binding on specific, but not all NF-B-dependent, promoters. Indeed, p65 ChIP assays revealed that IKK␣ is crucial for p65 binding on B sites of the icam-1 (intercellular adhesion molecule-1) and mcp-1 (monocyte chemoattractant protein-1) promoters but not on the ib␣ promoter. This binding requires IKK␣ catalytic activity and an intact nuclear localization sequence (NLS), suggesting that IKK␣ acts in the nucleus to mediate its effects. Further molecular studies demonstrated that IKK␣ modifies HDAC3 recruitment in a promoter-specific manner, thereby explaining its gene-specific activity.
EXPERIMENTAL PROCEDURES
Cell Culture, Antibodies, and Reagents-MEFs were cultured in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% of heat-inactivated fetal calf serum and 2 mM L-glutamine. Antibodies against p65 and HDAC3 were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA) (sc-109 for p65 ChIP and Western blotting, sc-372G for p65 immunocytochemistry, and sc-11417 for HDAC3 ChIP). The antibodies against IKK␣ were from Pharmingen (for Western blotting) and Santa Cruz Biotechnology (sc-7182 for immunocytochemistry). Antibody against IKK␤ was from Upstate Biotechnology (catalog number 05-035). Other antibodies were from StressGen (HSP60) and BD Transduction Laboratories (NBS1). Antibody against IB␣ was a gift from R. Hay (St. Andrews, UK). Alexa Fluor 488 donkey antigoat and 546 goat anti-rabbit antibodies were from Molecular Probes. Human recombinant TNF-␣ was from Peprotech, trichostatin A (TSA) was from Sigma, and SYBR green PCR master mix was from Applied Biosystems. Sodium pervanadate was prepared as described (29) .
Plasmids, Site-directed Mutagenesis, and Retroviral Gene Transfer-pMX retroviral vector containing human wildtype ikk␣ and ikk␣ AA were previously described (8) . The IKK␣ NLS mutant was generated by site-directed mutagenesis (Stratagene) by replacing Lys 235 , Lys 236 , and Lys 237 of WT IKK␣ with alanines. These constructs were transfected by the calcium phosphate method into 293T cells in combination with the pEC ampho expression vector (8) . Two days later, supernatants were collected and filtered prior to the transduction of ikk␣ Ϫ/Ϫ MEFs, and IKK␣ expression was confirmed by Western blotting.
Western Blotting and EMSA-Cytoplasmic and nuclear extracts were prepared as previously described (30) . Cytoplasmic extracts were analyzed by Western blotting as described (31) . Nuclear extracts and EMSA experiments were carried out as described (31) using 32 P-labeled oligonucleotide probes (Eurogentec) corresponding to the B site of the HIV-1 long terminal repeat.
Immunocytochemistry and Confocal Microscopy-p65 and IKK␣ nuclear translocation was visualized by confocal microscopy. To visualize p65, TNF-␣-treated MEFs were fixed with 4% paraformaldehyde and permeabilized with 0.3% Triton X-100. After washing with phosphate-buffered saline containing 10% fetal calf serum, slides were incubated with goat anti-p65 antibody (sc-372G; 1:100 dilution; Santa Cruz Biotechnology) for 1 h at 37°C and then washed and incubated with Alexa Fluor 488 donkey anti-goat antibody (1:400 dilution) for 1 h at 37°C. The slides were then washed, incubated with propidium iodide to visualize nuclei, mounted, and analyzed with a Leica TCS SP2 confocal microscope (Van Hopplynus). For IKK␣ immunolocalization, slides were incubated in 100% methanol at Ϫ20°C for 6 min and then washed with phosphate-buffered saline and blocked in phosphate-buffered saline containing 0.5% gelatin (Bio-Rad) and 0.25% bovine serum albumin (Invitrogen). Then cells were incubated with the primary antibody (sc-7182; 1:100 dilution; Santa Cruz Biotechnology) in blocking solution overnight at 4°C. After washing, cells were incubated with Alexa Fluor 546 goat anti-rabbit antibody (1:100 dilution) for 2 h at room temperature. Samples were mounted and analyzed with a LSM 510 Zeiss confocal microscope.
Chromatin Immunoprecipitation Assay-ChIP assays were carried out, and the solutions were prepared in our laboratory following the Upstate Cell Signaling protocol. After cross-linking with formaldehyde, treated cells were lysed and sonicated such that DNA fragments were 200 -1,000 base pairs in length. After a preclear with protein A-agarose beads saturated with herring sperm DNA (Sigma), extracts were incubated overnight with a rabbit polyclonal anti-p65 antibody (sc-109; 2 g; Santa Cruz Biotechnology) or HDAC3 antibody (sc-11417; 2 g; Santa Cruz Biotechnology). To take into account aspecific binding to the beads, a treated extract was also incubated with an irrelevant antibody (anti-FLAG; M2; Sigma). The next day, precipitation was carried out with saturated protein A-agarose beads. Cross-link was reversed at 65°C for 4 h, and precipitated DNA was purified using phenol/chloroform extraction. Quantitative PCR (using SYBR green PCR master mix; Applied Biosystems) was performed on the immunoprecipitated DNA by normalizing to input DNA for each sample. The following primers, amplifying specific B sites of the following genes, were used: icam-1 forward, 5Ј-CATTA-CTTCAGTTTGGAAATTCCTAGATC3Ј; icam-1 reverse, 5Ј-GGAACGAGGGCTTCGGTATT-3Ј; mcp-1 forward, 5Ј-CACCCCATTACATCTCTTCCCC-3Ј; mcp-1 reverse, 5Ј-TGTTTCCCTCTCACTTCACTCTGTC-3Ј; IB␣ forward, 5Ј-TGGCGAGGTCTGACTGTTGTGG-3Ј; IB␣ reverse, 5Ј-GCTCATCAAAAAGTTCC-CTGTGC-3Ј.
RESULTS

IKK␣ Is Required for NF-B DNA
Binding on an Exogenous B Element upon Pervanadate and TNF-␣ Stimulation-To assess potential additional roles of the IKK complex subunits beside the signal-induced degradation of the IB␣ proteins in the cytoplasm, we treated MEF cells with sodium pervanadate (Pv). This treatment induces tyrosine phosphorylation and subsequent degradation of IB␣ through a IKK-independent mechanism (12, 13, 29) . As revealed by an electromobility shift assay using a probe corresponding to the B site of the HIV-1 long terminal repeat, Pv induces a strong NF-B activation in WT MEFs, due to an almost complete degradation of IB␣ (Fig. 1A) . Interestingly, Pvinduced NF-B DNA binding activity is totally abolished in MEFs lacking both IKK␣ and IKK␤, despite unaltered IB␣ degradation (Fig.  1A) . The analysis of single knockout MEFs for either IKK␣ or IKK␤ revealed that the abolition of NF-B binding activity is still observable in ikk␣ Ϫ/Ϫ MEFs, but there is a partial recovery of NF-B DNA binding in ikk␤ Ϫ/Ϫ MEFs, suggesting that IKK␣ is required for NF-B DNA binding on an exogenous B element (Fig. 1A) . To further confirm the role of IKK␣ in NF-B binding, we reconstituted ikk␣ Ϫ/Ϫ MEFs with retroviral expression vectors encoding either wild-type IKK␣ or the inactivable IKK␣ mutant harboring the mutations S176A and S180A within the activation loop (IKK␣ AA) (32) . As control, we used ikk␣ Ϫ/Ϫ MEFs reconstituted with an empty vector. Western blot analysis confirmed the expression of IKK␣ in reconstituted MEFs (Fig. 1B) . We observed a recovery in NF-B DNA binding in ikk␣ Ϫ/Ϫ MEFs reconstituted with both IKK␣ WT and AA upon Pv stimulation but not in MEFs transduced with an empty vector (Fig. 1C) . The kinetics of IB␣ degradation were mostly the same in the three cell lines (Fig. 1C) . These data suggest that IKK␣ contributes to the NF-B DNA binding on an exogenous B element in Pvstimulated MEFs independently of its kinase activity. The same experiments were carried out with TNF-␣ as an inducer. Mobility shift assays revealed a clear inhibition of NF-B DNA binding in ikk␣ Ϫ/Ϫ MEFs transduced with an empty vector, com- for the indicated times. Nuclear extracts were analyzed by EMSA using a radioactive probe corresponding to the B consensus sequence of the HIV-1 long terminal repeat, and IB␣ degradation was detected by an anti-IB␣ blot performed on cytoplasmic extracts. B, ikk␣ Ϫ/Ϫ MEFs were infected with retrovirus containing either empty pMX vector or pMX encoding IKK␣ WT or AA. IKK␣ expression was checked by Western blotting. IKK␤ Western blotting was also carried out as loading control. C, ikk␣ Ϫ/Ϫ MEFs infected with retrovirus containing either empty pMX vector or pMX encoding IKK␣ WT or AA were treated with Pv. NF-B activation was analyzed by EMSA with nuclear extracts, and IB␣ degradation was detected by Western blotting with cytoplasmic extracts. pared with WT MEFs, despite a similar profile of IB␣ degradation ( Fig. 2A) . Reconstitution of ikk␣ Ϫ/Ϫ MEFs with IKK␣ WT or AA restored a normal NF-B binding upon TNF-␣ induction (Fig. 2B) . Altogether, these results suggest that IKK␣ is required for NF-B DNA binding independently of its kinase activity.
Mutation of IKK␣ Putative Nuclear Localization Signal Abrogates NF-B DNA Binding in Vitro-Recently, a putative NLS was identified within the kinase domain of IKK␣ (33) . To further explore whether IKK␣ must enter into the nucleus to modulate the NF-B DNA binding activity, we generated a mutant form of IKK␣ bearing alanines instead of three important lysines within its NLS (33) . This mutant failed to accumulate in the nucleus when overexpressed in 293T cells, whereas the wild-type IKK␣ did (Fig. 3A) . Next we reconstituted ikk␣ Ϫ/Ϫ MEFs with retrovirus encoding IKK␣ NLS mutant. Western blot analysis confirmed the expression of IKK␣ NLS-mutated in reconstituted MEFs (Fig. 3B) . To further characterize the functionality of IKK␣ NLS in MEFs, we carried out confocal microscopy. Detection of endogenous IKK␣ in WT MEFs revealed that the cellular distribution of IKK␣ is mainly cytoplasmic, but this protein also appears in the nucleus as speckles (Fig. 3C) . Similar results were obtained using ikk␣ Ϫ/Ϫ MEFs transduced with WT IKK␣ (Fig. 3C) . On the contrary, no nuclear distribution was observed using the NLS-mutated IKK␣ (Fig. 3C) . Absence of immunoreactivity in ikk␣ Ϫ/Ϫ MEFs confirmed antibody specificity (Fig. 3C) . This suggests that a small portion of IKK␣ enters within the nucleus in MEFs, and the mutation of IKK␣ NLS prevents this translocation. We next carried out a mobility shift experiment with MEFs expressing NLS-mutated IKK␣ compared with MEFs expressing WT IKK␣. TNF-␣ and Pv-induced NF-B DNA binding was strongly reduced in MEFs expressing NLS-mutated IKK␣, despite a quite unaltered IB␣ degradation (Fig. 3D) . These data suggest that a small fraction of IKK␣ functions in the nucleus enhancing NF-B DNA binding. MEFs reconstituted with an empty vector or expressing IKK␣ WT or AA (Fig. 4A ). p65 nuclear translocation was also observed in MEFs where the IKK␣ NLS was mutated. Interestingly, the basal level of nuclear p65 is more important compared with other cells (Fig. 4A) . Western blot analysis for cytoplasmic p65 revealed that its level of expression is constant across the analyzed cell lines (Fig. 4A) . The purity of extracts was controlled by reprobing the membrane with antibodies raised against NBS and HSP60 (Fig. 4A) . Unaltered p65 nuclear accumulation upon TNF-␣ stimulation of MEFs lacking IKK␣ or expressing IKK␣ NLS-mutated was further confirmed by immunolocalization of p65 using confocal microscopy (Fig. 4B ). This experiment also confirmed an elevated basal nuclear accumulation of p65 in MEFs IKK␣ NLS-mutated (Fig. 4B) . Altogether, we conclude that inhibition of NF-B activation observed by EMSA in the absence of IKK␣ or when IKK␣ NLS is mutated is not due to a lack of p65 translocation.
IKK␣ Mediates Recruitment of p65 on Specific NF-Bdependent Endogenous
Promoters-To extend our analyses, we used p65 ChIP assays to determine whether defects in NF-B DNA binding observed by electromobility shift assays were also confirmed on endogenous promoters. After chromatin immunoprecipitation with p65 antibody, real time PCR was used to amplify B consensus sequences of promoters of three NF-B target genes: icam-1, mcp-1, and ib␣. These genes were selected because they encode proteins important in inflammation and innate immunity (icam-1 and mcp-1) or for the negative feedback of NF-B regulation (ib␣). TNF-␣ treatment of WT MEFs induced two waves of p65 recruitment on icam-1 and mcp-1 promoter B sites, which reached a maximum at 30 and 120 min. However, p65 recruitment is clearly inhibited in ikk␣ Ϫ/Ϫ MEFs, particularly after 30 and 60 min of treatment (Fig. 5, A and B) . Interestingly, p65 recruitment on ib␣ promoter in ikk␣ Ϫ/Ϫ MEFs is slightly reduced but not totally inhibited, as observed for icam-1 and mcp-1 (Fig. 5C) . Similar results were obtained with the interleukin-6 promoter (data not shown). These data suggest that IKK␣ is required for p65 DNA binding on some but not all promoters. Reconstitution of ikk␣ Ϫ/Ϫ MEFs with a vector A, MEFs that were wild-type or transduced with either an empty vector or vector coding for IKK␣ WT, AA, or NLS-mutated were treated with TNF-␣ (200 units/ml) for the indicated times. Nuclear (N) and cytoplasmic (C) extracts were prepared and analyzed by Western blotting using p65 and IKK␣ antibodies. The membrane was then stripped and reprobed with antibodies against HSP60 and NBS1 to check the purity of the extracts. B, MEFs that were wild-type or transduced with either an empty vector or vector coding for IKK␣ WT, AA, or NLS-mutated were treated with TNF-␣ for the indicated times. p65 immunofluorescence was then carried out as described under "Experimental Procedures" with a specific antibody (green). Nuclei were visualized using propidium iodide staining (red). Ctrl, control. JULY 20, 2007 • VOLUME 282 • NUMBER 29
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at UNIV DE LIEGE-MME F PASLE on July 18, 2007 www.jbc.org encoding WT IKK␣ completely restored recruitment of p65 on icam-1 and mcp-1 promoters, whereas no changes were observed regarding p65 DNA binding on ib␣ promoter (Fig. 6, A-C) . Complementation of ikk␣ Ϫ/Ϫ MEFs with IKK␣ AA or NLS clearly inhibits p65 recruitment on icam-1 and mcp-1 promoters but not on the ib␣ promoter (Fig. 6,  A-C) . In this case, an increase in p65 DNA binding is even observed (Fig. 6C) . Collectively, these experiments prompt us to conclude that IKK␣ is crucial for p65 DNA binding on some but not all promoters. Indeed, the ib␣ promoter does not seem to require IKK␣ for p65 recruitment, whereas icam-1 and mcp-1 promoters do. p65 recruitment on these promoters is abrogated by IKK␣ AA or NLS mutations, whereas these mutations rather enhance p65 binding on the ib␣ promoter.
Inhibition of p65 Binding on icam-1 and mcp-1 Promoters in ikk␣
Ϫ/Ϫ MEFs Is Relieved by TSA Pretreatment-Acetylation has been described as a critical posttranslational mechanism regulating p65 DNA binding activity (34, 35) , and treatment of cells with TSA, an HDAC inhibitor, potentiated NF-B activation induced by TNF-␣ (36). This observation suggests that inhibition of HDAC activity is critical for a correct NF-B DNA binding. Therefore, we wanted to explore whether TSA pretreatment modifies p65 DNA binding in ikk␣ Ϫ/Ϫ MEFs treated with TNF-␣. TSA restored normal p65 recruitment on icam-1 and mcp-1 promoters in ikk␣ Ϫ/Ϫ MEFs (Fig. 7, A and B) , reaching values similar to those obtained in WT MEFs (see Fig. 5 ). Conversely, TSA pretreatment did not increase p65 binding on the ib␣ promoter (Fig. 7C) . Altogether, these data suggest that TSA can substitute for IKK␣ for NF-B DNA binding on specific promoters.
HDAC3 Recruitment on icam-1 and ib␣ Promoters Is Oppositely
Regulated by IKK␣-The results obtained with TSA pretreatment led us to further explore the role of HDACs in IKK␣-mediated p65 DNA binding. HDAC3, a class I histone deacetylase, has been reported to directly deacetylate p65, thereby inhibiting its DNA binding (34) . HDAC3 is associated with NF-B-dependent promoters and negatively regulates NF-Bdependent transcription together with co-repressors, such as SMRT (20) . Using laminin attachment to activate NF-B, it was reported that IKK␣ directly removes SMRT and HDAC3 from promoters, thereby allowing NF-B-mediated transcription (20) . Thus, we studied the recruitment of HDAC3 on the promoters of two genes differentially regulated by IKK␣ (i.e. icam-1 and ib␣) upon TNF-␣ stimulation. In ikk␣ Ϫ/Ϫ MEFs expressing WT IKK␣, TNF-␣ induces a slight removal of HDAC3 from the icam-1 promoter (Fig. 8A) . On the contrary, HDAC3 is dramatically recruited in MEFS lacking IKK␣ and reconstituted with IKK␣ AA or NLS-mutated (Fig. 8A) . No change in chromatin-bound HDAC3 was observed on the ib␣ promoter in WT MEFs stimulated with TNF-␣ (Fig. 8B) , whereas a dramatic removal is induced in ikk␣ Ϫ/Ϫ MEFs or MEFs expressing IKK␣ AA or NLS-mutated (Fig. 8B) . This FIGURE 5 . IKK␣ mediates recruitment of p65 on specific NF-B-dependent endogenous promoters. MEFs that were wild-type or IKK␣-deficient were treated with TNF-␣ for the indicated times. CHiP assays using a p65 antibody were performed as described under "Experimental Procedures." Real time PCR was then carried out on immunoprecipitated DNA using primers amplifying B sites of promoters of icam-1 (A), mcp-1 (B), and ib␣ (C) genes.
HDAC3 removal is not induced by the prior p65 DNA binding, since it is still observable in p65 KO MEFs stimulated with TNF-␣ (data not shown). Collectively, these results suggest that IKK␣ oppositely regulates the dynamic of HDAC3 recruitment on icam-1 and ib␣ promoters.
DISCUSSION
The study of nuclear events involved in NF-B activation is the focus of intensive research in many laboratories. IKK␣, one of the subunits of the IKK complex, has recently been associated with NF-B nuclear action, notably through its phosphorylation of histone H3, a component of nucleosomes (21, 23) . However, the precise nuclear functions of IKK␣ are poorly understood. Here, the use of IKKindependent pathways triggering IB␣ degradation (i.e. sodium pervanadate stimulation) allowed us to study the precise nuclear roles of IKK subunits in MEFs defective for IKK␣ and IKK␤. We found that IKK␣ is crucial for NF-B DNA binding on an exogenous B element, whereas IKK␤ seems less important. TNF-␣ stimulation gave rise to the same results. This is in agreement with other studies demonstrating that the absence of IKK␣ inhibits NF-B DNA binding activity in HeLa cells or mouse embryonic fibroblasts (25, 26) . The complementation of ikk␣ Ϫ/Ϫ MEFs with either WT or inactivable (AA) IKK␣ totally rescued NF-B DNA binding upon Pv and TNF-␣ stimulation, suggesting that IKK␣ kinase activity is not required for this function. Meanwhile, mutation of important residues in a putative NLS within IKK␣, thereby preventing its nuclear translocation, dramatically inhibited NF-B DNA binding on an exogenous B element. This suggests that IKK␣ acts in the nucleus to enhance NF-B DNA binding. Indeed, we clearly observed a nuclear distribution of IKK␣ as speckles in WT MEFs or ikk␣ Ϫ/Ϫ MEFs reexpressing IKK␣ WT, whereas mutation of IKK␣ NLS prevented this accumulation. We thus propose that a small portion of IKK␣ enters the nucleus to regulate chromatin events. This result seems to conflict with another work reporting an important nuclear accumulation of IKK␣ after TNF-␣ stimulation (21) . We never observed such a massive translocation upon TNF-␣ treatment (data not shown). These discrepant results probably reflect technical differences between laboratories in the design of experiments. For example, the use of ikk␣ Ϫ/Ϫ cells to take into account aspecific binding of antibodies appears highly desirable to avoid artifactual results. In a more general context, IKK␣ nuclear translocation is still a matter of debate in literature. Whereas some researchers observe high levels of IKK␣ in the nucleus of various cell types (21, 23, 33, 37) , others fail to detect any nuclear IKK␣ and even use this protein as a negative control in their ChIP experiments (38) . These discrepancies probably reflect cell type-specific functions of IKK␣.
Confocal microscopy experiments and p65 blots on cytoplasmic and nuclear fractions clearly demonstrated that the absence of NF-B DNA binding in MEFs defective for IKK␣ or expressing IKK␣ NLS-mutated was not due to an inhibition of p65 nuclear translocation. Interestingly, MEFs expressing IKK␣ NLS-mutated exhibit a constitutive nuclear accumulation of p65, suggesting that IKK␣ regulates p65 nucleo-cytoplasmic shuttling. Recently, Lawrence et al. (24) highlighted a role for IKK␣ in accelerating promoter clearance of p65 in macrophages, thereby contributing to the resolution of inflammation. This could explain the enhanced p65 nuclear accumulation observed in MEFs IKK␣ NLS-mutated, although, in this case, p65 is not found to be associated with target promoters.
In a second part, we extended our EMSA analyses to p65 ChIP assays. These experiments confirmed the dramatic decrease of p65 binding on icam-1 and mcp-1 promoters, two NF-B target genes, in IKK␣ KO MEFs stimulated with TNF-␣. On the contrary, the ib␣ promoter does not seem to require IKK␣ for p65 binding, highlighting a promoter-specific function for IKK␣. Normal p65 binding on the ib␣ promoter in the absence of IKK␣ was also reported by other groups (21, 23) , suggesting that this promoter behaves differently from icam-1 and mcp-1. p65 ChIP also confirmed the crucial role of IKK␣ NLS sequence for p65 binding, suggesting that IKK␣ must enter into the nucleus to achieve its roles. Interestingly, IKK␣ catalytic activity seems to be also required for p65 DNA binding on endogenous icam-1 and mcp-1 promoters, whereas EMSA experiments revealed no change in NF-B binding on an exogenous B element using MEFs expressing IKK␣ AA. This suggests that IKK␣ has a dual function in p65 DNA binding. First, the requirement of nuclear IKK␣ for direct p65 binding on both exogenous B elements and endogenous promoters suggests that IKK␣ directly modifies p65 to allow its DNA binding. This modification is likely to be acetylation, since IKK␣ has been recently reported to interact with CREB-binding protein, a histone acetyltransferase capable of acetylating p65 and thus enhancing its DNA binding (23, 34) . IKK␣ might thus act as a nuclear scaffold protein required for the post-translational modifications of transcription factors, thereby enhancing their DNA binding capacities. The second role of IKK␣ involves its catalytic activity in the chromatin context. Hoberg et al. (20) recently reported that IKK␣ activity was necessary to phosphorylate the chromatin-bound corepressor SMRT, thereby inducing its removal together with HDAC3. This mechanism, deciphered upon NF-B activation induced by laminin attachment, is likely to be the same in our system. Indeed, we observed a dramatic recruitment of HDAC3 on the icam-1 promoter in MEFs lacking IKK␣ or expressing IKK␣ AA or NLS-mutated stimulated with TNF-␣. One hypothesis is that promoter-bound HDAC3 inhibits p65 binding on the icam-1 promoter by inducing its deacetylation, since this inhibition is relieved by TSA pretreatment. To further confirm this hypothesis, we transduced p65 KO MEFs with retroviruses encoding WT p65 or a hypoacetylated mutant containing a lysine to arginine substitution at the position 221, one major acetylation site of p65 (34) . As already described, we found out that p65 K221R does not bind DNA due to a defect in nuclear translocation (data not shown). This -1 (A), mcp-1 (B) , and ib␣ (C) promoters in ikk␣ ؊/؊ MEFs is relieved by TSA pretreatment. ikk␣ Ϫ/Ϫ MEFs were pretreated or not with TSA (450 M, 2 h) and then stimulated with TNF-␣ (200 units/ml) for the indicated times. CHiP assays using a p65 antibody were then performed as described in the legend to Fig. 5 .
